Video

Dr. Saba on Immunotherapy/Radiation Combo in Head and Neck Cancer

Nabil F. Saba, MD, FACP, discusses the potential benefit of immunotherapy in combination with radiation in head and neck cancer.

Nabil F. Saba, MD, FACP, director, Head and Neck Medical Oncology Program, Winship Cancer Institute of Emory University, professor, Department of Hematology and Medical Oncology, Department of Otolaryngology, Emory University School of Medicine, discusses the potential benefit of immunotherapy in combination with radiation in head and neck cancer.

Historically, patients who receive chemotherapy and radiation experience significant long-term toxicities, says Saba. These adverse events may affect a patient’s swallowing andrespiratory function and could lead to disfigurement.

The combination of immunotherapy and radiation could be a way to mitigate these toxicities. The approach appears to have similar efficacy as chemotherapy while preserving quality of life for patients. Ongoing trials combining immune checkpoint inhibitors with radiation in the reirradiation setting are ongoing, explains Saba. Ultimately, the goal is to develop a curative approach with less toxicity.

Related Videos
Daniel DeAngelo, MD, PhD
Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, co-director, Hematology-Oncology System, New York University (NYU) Grossman Long Island School of Medicine
Douglas W. Sborov, MD, MS, associate professor, Department of Internal Medicine—Division of Hematology and Hematologic Malignancies; director, Hematology Disease Center and Plasma Cell Dyscrasias Program, the University of Utah Huntsman Cancer Institute
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Binod Dhakal, MD
Sheldon M. Feldman, MD
Yair Lotan, MD, UT Southwestern Medical Center
Alan Tan, MD, Vanderbilt-Ingram Cancer Center